首页 > 最新文献

Arquivos de Gastroenterologia最新文献

英文 中文
PERCUTANEOUS CHOLANGIOSCOPY AND LASER BILIARY LITHOTRIPSY FOR BILIARY INTRAHEPATIC STONES MANAGEMENT: CASE REPORT. 经皮胆道镜和激光胆道碎石术治疗胆道肝内结石:病例报告。
Q2 Medicine Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-006
Alan Junior de Aguiar, Paula Heroso Moreira, Fernanda Biasi da Cunha, João Vitor Bacarin, Pedro Henrique Batista Santini, Eduardo Aimore Bonin

Intrahepatic biliary stone disease is a difficult condition to treat, due to anatomical complexity of biliary tract, association with colestasis, and high recurrence rates, with potential short- and long-term complications, such as cholangitis and secondary biliary cirrhosis. Removal of biliary stones via intraductal access can be achieved endoscopically or percutaneously, with preference for cholangioscopy-guided laser lithotripsy in complex cases. The surgical approach, despite its prolonged results, is a more invasive and risky procedure. The authors present a case of cholangioscopy with percutaneous laser biliary lithotripsy as an option for the treatment of intrahepatic biliary stone disease associated with biliary stricture following biliodigestive anastomosis due to bile duct injury following cholecystectomy, a safe and effective alternative with low morbidity and satisfactory outcomes in follow-up.

肝内胆道结石病是一种难以治疗的疾病,这是因为胆道解剖结构复杂,与结肠淤血有关,复发率高,并可能出现短期和长期并发症,如胆管炎和继发性胆汁性肝硬化。经导管内入路取出胆道结石的方法有内镜或经皮两种,复杂病例首选胆道镜引导下激光碎石术。手术方法虽然疗效显著,但创伤更大,风险更高。作者介绍了一例采用胆道镜加经皮激光胆道碎石术治疗胆囊切除术后胆管损伤导致胆总管吻合术后胆道狭窄伴肝内胆管结石病的病例,该方法安全有效,发病率低,随访结果令人满意。
{"title":"PERCUTANEOUS CHOLANGIOSCOPY AND LASER BILIARY LITHOTRIPSY FOR BILIARY INTRAHEPATIC STONES MANAGEMENT: CASE REPORT.","authors":"Alan Junior de Aguiar, Paula Heroso Moreira, Fernanda Biasi da Cunha, João Vitor Bacarin, Pedro Henrique Batista Santini, Eduardo Aimore Bonin","doi":"10.1590/S0004-2803.24612024-006","DOIUrl":"10.1590/S0004-2803.24612024-006","url":null,"abstract":"<p><p>Intrahepatic biliary stone disease is a difficult condition to treat, due to anatomical complexity of biliary tract, association with colestasis, and high recurrence rates, with potential short- and long-term complications, such as cholangitis and secondary biliary cirrhosis. Removal of biliary stones via intraductal access can be achieved endoscopically or percutaneously, with preference for cholangioscopy-guided laser lithotripsy in complex cases. The surgical approach, despite its prolonged results, is a more invasive and risky procedure. The authors present a case of cholangioscopy with percutaneous laser biliary lithotripsy as an option for the treatment of intrahepatic biliary stone disease associated with biliary stricture following biliodigestive anastomosis due to bile duct injury following cholecystectomy, a safe and effective alternative with low morbidity and satisfactory outcomes in follow-up.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24006"},"PeriodicalIF":0.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NON-ALCOHOLIC FATTY LIVER DISEASE AND EXTRA-HEPATIC CANCER: A NARRATIVE REVIEW. 非酒精性脂肪肝和肝外癌症:叙述性综述。
Q2 Medicine Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-027
Achiles Queiroz Monteiro de Rezende, Everton Cazzo

Background: Recently, significant associations between non-alcoholic fatty liver disease (NAFLD) and extra-hepatic cancer have been reported.

Objective: To carry out a comprehensive review of the current evidence in the literature on the association between NAFLD and extra-hepatic cancer.

Methods: A narrative literature review was performed through an online search for the MeSH terms "fatty liver" and "cancer" in MEDLINE (via PubMed) and LILACS (via BVS). Original studies that described the impact of NAFLD on different types of extra-hepatic malignancies were included.

Results: After careful analysis, nine prospective cohort studies, one retrospective cohort study, three case-control studies, and three cross-sectional studies were selected.

Conclusion: There is consistent evidence on the association between NAFLD and extra-hepatic carcinogenesis, especially in relation to colorectal, gastric, pancreatic, breast, prostate, and bladder cancers.

背景:最近有报道称,非酒精性脂肪肝(NAFLD)与肝外癌之间存在显著关联:最近,有报道称非酒精性脂肪肝(NAFLD)与肝外癌之间存在重大关联:全面回顾非酒精性脂肪肝与肝外癌之间关系的现有文献证据:方法:在MEDLINE(通过PubMed)和LILACS(通过BVS)中以MeSH术语 "脂肪肝 "和 "癌症 "为关键词进行在线检索,对叙述性文献进行综述。结果:经过仔细分析,共筛选出 9 项前瞻性队列研究、1 项回顾性队列研究、3 项病例对照研究和 3 项横断面研究:结论:有一致的证据表明非酒精性脂肪肝与肝外癌变有关,特别是与结直肠癌、胃癌、胰腺癌、乳腺癌、前列腺癌和膀胱癌有关。
{"title":"NON-ALCOHOLIC FATTY LIVER DISEASE AND EXTRA-HEPATIC CANCER: A NARRATIVE REVIEW.","authors":"Achiles Queiroz Monteiro de Rezende, Everton Cazzo","doi":"10.1590/S0004-2803.24612023-027","DOIUrl":"10.1590/S0004-2803.24612023-027","url":null,"abstract":"<p><strong>Background: </strong>Recently, significant associations between non-alcoholic fatty liver disease (NAFLD) and extra-hepatic cancer have been reported.</p><p><strong>Objective: </strong>To carry out a comprehensive review of the current evidence in the literature on the association between NAFLD and extra-hepatic cancer.</p><p><strong>Methods: </strong>A narrative literature review was performed through an online search for the MeSH terms \"fatty liver\" and \"cancer\" in MEDLINE (via PubMed) and LILACS (via BVS). Original studies that described the impact of NAFLD on different types of extra-hepatic malignancies were included.</p><p><strong>Results: </strong>After careful analysis, nine prospective cohort studies, one retrospective cohort study, three case-control studies, and three cross-sectional studies were selected.</p><p><strong>Conclusion: </strong>There is consistent evidence on the association between NAFLD and extra-hepatic carcinogenesis, especially in relation to colorectal, gastric, pancreatic, breast, prostate, and bladder cancers.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23027"},"PeriodicalIF":0.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FACTORS ASSOCIATED WITH A HIGHER NUMBER OF ESOPHAGEAL DILATIONS IN CHILDREN WITH A HISTORY OF ALKALINE INGESTION. 有碱性食物摄入史的儿童食管扩张次数较多的相关因素。
Q2 Medicine Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-061
Annie J Cardoso, Natascha S Sandy, Gabriela S Gomez, Maria de Fatima Servidoni, Elizete A Lomazi, Maria Angela Bellomo-Brandao

Background: Children who experience alkaline injury are at risk for the development of esophageal strictures and the need for esophageal dilations.

Objective: We aimed to assess predictors for a higher number of esophageal dilatations in children following alkali ingestion.

Methods: Single-center retrospective cohort study including children who underwent esophagogastroduodenoscopy (EGD) after alkali ingestion. Possible predictive factors for the need for esophageal dilatations were evaluated.

Results: A total of 34 patients were included, and 19 were female (55.9%). The median age at the time of the accidents was 20.6 months (IQR 15-30.7). All alkali ingestions were accidental, in all cases involving liquid products, and most (24/34; 70%) occurred at the child's home. Homemade liquid soap was the agent in half of the cases. The most frequently reported symptom at presentation was vomiting (22/34, 64.7%). The median follow-up time was 3.2 years (IQR 1.1-7.4). On follow-up, the median number of esophageal dilatations required for these patients was 12.5 (IQR 0-34). Among demographic factors, male gender (P=0.04), ingestion of homemade products (P<0.01), and accidents happening outside of the household environment (P=0.02) were associated with a greater number of esophageal dilations on follow-up. An endoscopic classification Zargar of 2B or higher (P=0.03), the presence of stricture at the time of the second EGD (P=0.01), and gastroesophageal reflux disease (GERD) as a late complication (P=0.01) were also associated with a greater number of esophageal dilations on long term follow-up.

Conclusion: Beyond the endoscopic classification severity - a well-known risk factor for the strictures after alkali ingestions, we found that male gender, accidents with homemade products, and accidents occurring outside the household environment were significantly associated with a greater number of esophageal dilatations in the long-term follow-up of children following alkali ingestion.

背景:受到碱性物质伤害的儿童有发生食管狭窄和需要进行食管扩张的风险:我们的目的是评估儿童摄入碱性物质后食管扩张次数增加的预测因素:单中心回顾性队列研究,包括食碱后接受食管胃十二指肠镜检查(EGD)的儿童。结果:共纳入 34 名患者,其中有 3 名儿童需要进行食管扩张:共纳入 34 名患者,其中 19 人为女性(55.9%)。事故发生时的中位年龄为 20.6 个月(IQR 15-30.7)。所有碱摄入均为意外,所有病例均涉及液体产品,大部分(24/34;70%)发生在儿童家中。半数病例的病原体是自制的液体肥皂。报告最多的症状是呕吐(22/34,64.7%)。随访时间的中位数为 3.2 年(IQR 1.1-7.4)。随访期间,这些患者所需的食管扩张次数中位数为 12.5 次(IQR 0-34)。在人口统计学因素中,男性(P=0.04)、摄入自制产品(PConclusion:内镜分类的严重程度是众所周知的食碱摄入后狭窄的风险因素,除此之外,我们还发现,在对食碱摄入后儿童的长期随访中,男性性别、使用自制产品的意外事故以及发生在家庭环境之外的意外事故与食管扩张次数的增加显著相关。
{"title":"FACTORS ASSOCIATED WITH A HIGHER NUMBER OF ESOPHAGEAL DILATIONS IN CHILDREN WITH A HISTORY OF ALKALINE INGESTION.","authors":"Annie J Cardoso, Natascha S Sandy, Gabriela S Gomez, Maria de Fatima Servidoni, Elizete A Lomazi, Maria Angela Bellomo-Brandao","doi":"10.1590/S0004-2803.24612023-061","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612023-061","url":null,"abstract":"<p><strong>Background: </strong>Children who experience alkaline injury are at risk for the development of esophageal strictures and the need for esophageal dilations.</p><p><strong>Objective: </strong>We aimed to assess predictors for a higher number of esophageal dilatations in children following alkali ingestion.</p><p><strong>Methods: </strong>Single-center retrospective cohort study including children who underwent esophagogastroduodenoscopy (EGD) after alkali ingestion. Possible predictive factors for the need for esophageal dilatations were evaluated.</p><p><strong>Results: </strong>A total of 34 patients were included, and 19 were female (55.9%). The median age at the time of the accidents was 20.6 months (IQR 15-30.7). All alkali ingestions were accidental, in all cases involving liquid products, and most (24/34; 70%) occurred at the child's home. Homemade liquid soap was the agent in half of the cases. The most frequently reported symptom at presentation was vomiting (22/34, 64.7%). The median follow-up time was 3.2 years (IQR 1.1-7.4). On follow-up, the median number of esophageal dilatations required for these patients was 12.5 (IQR 0-34). Among demographic factors, male gender (P=0.04), ingestion of homemade products (P<0.01), and accidents happening outside of the household environment (P=0.02) were associated with a greater number of esophageal dilations on follow-up. An endoscopic classification Zargar of 2B or higher (P=0.03), the presence of stricture at the time of the second EGD (P=0.01), and gastroesophageal reflux disease (GERD) as a late complication (P=0.01) were also associated with a greater number of esophageal dilations on long term follow-up.</p><p><strong>Conclusion: </strong>Beyond the endoscopic classification severity - a well-known risk factor for the strictures after alkali ingestions, we found that male gender, accidents with homemade products, and accidents occurring outside the household environment were significantly associated with a greater number of esophageal dilatations in the long-term follow-up of children following alkali ingestion.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23061"},"PeriodicalIF":0.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INFLUENCE OF ESOPHAGEAL MOTILITY IMPAIRMENT ON UPPER AND LOWER ESOPHAGEAL SPHINCTER PRESSURE IN CHAGAS DISEASE. 恰加斯病食管运动障碍对食管上、下括约肌压力的影响
Q2 Medicine Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-174
Roberto Oliveira Dantas

Background: Chagas disease causes digestive anatomic and functional changes, including the loss of the myenteric plexus and abnormal esophageal radiologic and manometric findings.

Objective: To evaluate the association of abnormal esophageal radiologic findings, cardiac changes, distal esophageal contractions, and complaints of dysphagia and constipation in upper (UES) and lower (LES) esophageal sphincter basal pressure in Chagas disease patients.

Methods: The study evaluated 99 patients with Chagas disease and 40 asymptomatic normal volunteers. The patients had normal esophageal radiologic examination (n=61) or esophageal retention without an increase in esophageal diameter (n=38). UES and LES pressure was measured with the rapid pull-through method in a 4-channel water-perfused round catheter. Before manometry, the patients were asked about dysphagia and constipation and submitted to electrocardiography and chest radiography.

Results: The amplitude of esophageal distal contraction decreased from controls to chagasic patients with esophageal retention. The proportion of failed and simultaneous contractions increased in patients with abnormal radiologic examination (P<0.01). There were no significant differences in UES and LES pressure between the groups. UES pressure was similar between Chagas disease patients with cardiomegaly (n=27, 126.5±62.7 mmHg) and those without it (n=72, 144.2±51.6 mmHg, P=0.26). Patients with constipation had lower LES pressure (n=23, 34.7±20.3 mmHg) than those without it (n=76, 42.9±20.5 mmHg, P<0.03).

Conclusion: Chagas disease patients with absent or mild esophageal radiologic involvement had no significant changes in UES and LES basal pressure. Constipation complaints are associated with decreased LES basal pressure.

背景:恰加斯病会导致消化系统解剖和功能的改变,包括肠肌丛缺失、食管放射学和人体测量学结果异常:评估恰加斯病患者食管放射学检查结果异常、心脏变化、食管远端收缩以及吞咽困难和便秘主诉与食管上括约肌(UES)和食管下括约肌(LES)基础压力之间的关联:研究评估了 99 名恰加斯病患者和 40 名无症状的正常志愿者。患者的食管放射学检查结果正常(61 人)或食管潴留但食管直径没有增加(38 人)。采用快速拉通法在 4 道水灌注圆形导管中测量 UES 和 LES 压力。测压前,询问患者是否有吞咽困难和便秘,并进行心电图和胸片检查:结果:从对照组到患有食管潴留的恰加斯病患者,食管远端收缩的幅度都有所下降。在放射学检查异常的患者中,收缩失败和同时收缩的比例增加(PC结论:没有食管放射学受累或受累程度较轻的恰加斯病患者的 UES 和 LES 基础压力没有明显变化。便秘主诉与LES基础压力下降有关。
{"title":"INFLUENCE OF ESOPHAGEAL MOTILITY IMPAIRMENT ON UPPER AND LOWER ESOPHAGEAL SPHINCTER PRESSURE IN CHAGAS DISEASE.","authors":"Roberto Oliveira Dantas","doi":"10.1590/S0004-2803.24612023-174","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612023-174","url":null,"abstract":"<p><strong>Background: </strong>Chagas disease causes digestive anatomic and functional changes, including the loss of the myenteric plexus and abnormal esophageal radiologic and manometric findings.</p><p><strong>Objective: </strong>To evaluate the association of abnormal esophageal radiologic findings, cardiac changes, distal esophageal contractions, and complaints of dysphagia and constipation in upper (UES) and lower (LES) esophageal sphincter basal pressure in Chagas disease patients.</p><p><strong>Methods: </strong>The study evaluated 99 patients with Chagas disease and 40 asymptomatic normal volunteers. The patients had normal esophageal radiologic examination (n=61) or esophageal retention without an increase in esophageal diameter (n=38). UES and LES pressure was measured with the rapid pull-through method in a 4-channel water-perfused round catheter. Before manometry, the patients were asked about dysphagia and constipation and submitted to electrocardiography and chest radiography.</p><p><strong>Results: </strong>The amplitude of esophageal distal contraction decreased from controls to chagasic patients with esophageal retention. The proportion of failed and simultaneous contractions increased in patients with abnormal radiologic examination (P<0.01). There were no significant differences in UES and LES pressure between the groups. UES pressure was similar between Chagas disease patients with cardiomegaly (n=27, 126.5±62.7 mmHg) and those without it (n=72, 144.2±51.6 mmHg, P=0.26). Patients with constipation had lower LES pressure (n=23, 34.7±20.3 mmHg) than those without it (n=76, 42.9±20.5 mmHg, P<0.03).</p><p><strong>Conclusion: </strong>Chagas disease patients with absent or mild esophageal radiologic involvement had no significant changes in UES and LES basal pressure. Constipation complaints are associated with decreased LES basal pressure.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23174"},"PeriodicalIF":0.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TEN-YEAR OUTCOMES OF TIPS FOR BUDD-CHIARI SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS. 布氏-奇异综合征提示的十年结果:系统回顾和荟萃分析。
Q2 Medicine Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-171
Mariana Oliveira Amarante Moreno, Cláudio Luiz da Silva Lima Paz, Maria Gabriela Fernandes Dezan, Lourianne Nascimento Cavalcante, Andre Castro Lyra

Background: Budd-Chiari syndrome (BCS) results from the obstruction of the hepatic venous flow, usually at the level of the hepatic vein or inferior vena cava. When left untreated, it can progress with several complications, including liver cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) appears to be effective in a subgroup of BCS patients.

Objective: To perform a systematic review and meta-analysis of TIPS effectiveness in BCS treatment, considering the survival rate, reduction in portosystemic pressure, need for liver transplantation, technical failure, and shunt dysfunction for up to 10 years of follow-up.

Methods: We evaluated 17 studies published in PubMed, Science Direct, Web of Science, and SCOPUS databases, which used TIPS as a treatment for BCS, comprising 618 subjects between 18 and 78 years old. We assessed the bias risk by the NOS, NHI, and JBI scales for cohort stu-dies, before-after studies, and case series, respectively. We conducted the meta-analyses by extracting the number of events and the total patients evaluated to perform the proportion meta-analyses using the R software ("meta" package - version 4.9-6).

Results: The pooled results (95%CI) showed a 19% (25.9-12.5%) rate of portosystemic pressure reduction, 6% (1-12%) rate for the need for liver transplants despite the use of TIPS, 2% (1-6%) technical failure rate, 30% (18-46%) shunt dysfunction rate, and 88% (81-93%) for the mean frequency of patients alive between 1 and 10 years after the procedure. We stratified survival rate and found an 86% (74-93%) prevalence of living subjects during less than five years, 92% (83-97%) at five years, and a 77% frequency (68-83%) of patients alive ten years after the TIPS placement.

Conclusion: TIPS is an effective treatment for BCS, providing a high 10-year frequency of living patients and a significant decrease in portosystemic pressure. The need for liver transplants after TIPS and the technical failure rate is low.

背景:巴德-卡氏综合征(BCS)是肝静脉血流受阻所致,通常发生在肝静脉或下腔静脉。如果不及时治疗,会引发多种并发症,包括肝硬化。经颈静脉肝内门体分流术(TIPS)似乎对一部分 BCS 患者有效:对经颈静脉肝内门体分流术治疗 BCS 的有效性进行系统回顾和荟萃分析,考虑随访长达 10 年的生存率、门脉压力降低、肝移植需求、技术失败和分流功能障碍等因素:我们评估了发表在 PubMed、Science Direct、Web of Science 和 SCOPUS 数据库中的 17 项使用 TIPS 治疗 BCS 的研究,其中包括 618 名年龄在 18 到 78 岁之间的受试者。我们分别用 NOS、NHI 和 JBI 量表评估了队列研究、前后研究和病例系列研究的偏倚风险。我们使用R软件("meta "软件包--4.9-6版)提取事件数和接受评估的患者总数,进行比例荟萃分析:汇总结果(95%CI)显示,门静脉压力降低率为19%(25.9%-12.5%),尽管使用了TIPS,但仍需进行肝移植的比例为6%(1%-12%),技术失败率为2%(1%-6%),分流功能障碍率为30%(18%-46%),术后1至10年存活患者的平均频率为88%(81%-93%)。我们对存活率进行了分层,发现存活不足 5 年的患者比例为 86%(74-93%),5 年后为 92%(83-97%),TIPS 置入 10 年后存活的患者比例为 77%(68-83%):结论:TIPS 是一种治疗 BCS 的有效方法,患者十年内存活率高,门静脉压力显著降低。TIPS术后的肝移植需求和技术失败率都很低。
{"title":"TEN-YEAR OUTCOMES OF TIPS FOR BUDD-CHIARI SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS.","authors":"Mariana Oliveira Amarante Moreno, Cláudio Luiz da Silva Lima Paz, Maria Gabriela Fernandes Dezan, Lourianne Nascimento Cavalcante, Andre Castro Lyra","doi":"10.1590/S0004-2803.24612023-171","DOIUrl":"10.1590/S0004-2803.24612023-171","url":null,"abstract":"<p><strong>Background: </strong>Budd-Chiari syndrome (BCS) results from the obstruction of the hepatic venous flow, usually at the level of the hepatic vein or inferior vena cava. When left untreated, it can progress with several complications, including liver cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) appears to be effective in a subgroup of BCS patients.</p><p><strong>Objective: </strong>To perform a systematic review and meta-analysis of TIPS effectiveness in BCS treatment, considering the survival rate, reduction in portosystemic pressure, need for liver transplantation, technical failure, and shunt dysfunction for up to 10 years of follow-up.</p><p><strong>Methods: </strong>We evaluated 17 studies published in PubMed, Science Direct, Web of Science, and SCOPUS databases, which used TIPS as a treatment for BCS, comprising 618 subjects between 18 and 78 years old. We assessed the bias risk by the NOS, NHI, and JBI scales for cohort stu-dies, before-after studies, and case series, respectively. We conducted the meta-analyses by extracting the number of events and the total patients evaluated to perform the proportion meta-analyses using the R software (\"meta\" package - version 4.9-6).</p><p><strong>Results: </strong>The pooled results (95%CI) showed a 19% (25.9-12.5%) rate of portosystemic pressure reduction, 6% (1-12%) rate for the need for liver transplants despite the use of TIPS, 2% (1-6%) technical failure rate, 30% (18-46%) shunt dysfunction rate, and 88% (81-93%) for the mean frequency of patients alive between 1 and 10 years after the procedure. We stratified survival rate and found an 86% (74-93%) prevalence of living subjects during less than five years, 92% (83-97%) at five years, and a 77% frequency (68-83%) of patients alive ten years after the TIPS placement.</p><p><strong>Conclusion: </strong>TIPS is an effective treatment for BCS, providing a high 10-year frequency of living patients and a significant decrease in portosystemic pressure. The need for liver transplants after TIPS and the technical failure rate is low.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23171"},"PeriodicalIF":0.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误。
Q2 Medicine Pub Date : 2024-05-20 DOI: 10.1590/S0004-2803.24612024-e24c01

[This corrects the article doi: 10.1590/S0004-2803.24612023-117].

[此处更正了文章 doi:10.1590/S0004-2803.24612023-117]。
{"title":"Erratum.","authors":"","doi":"10.1590/S0004-2803.24612024-e24c01","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-e24c01","url":null,"abstract":"<p><p>[This corrects the article doi: 10.1590/S0004-2803.24612023-117].</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24c01"},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DECREASED EXPRESSION OF MICRORNA-629 IN GASTRIC CANCER SAMPLES POTENTIATED BY THE VIRULENCE MARKER OF H. PYLORI, CAGA GENE. 幽门螺杆菌的毒力标记--caga 基因导致胃癌样本中的 microrna-629 表达量减少。
Q2 Medicine Pub Date : 2024-05-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-139
Caroline Dos Reis Rodrigues Soares, Lucas Matheus Vieira da Silva, Bianca Reis Almeida, Jéssica Nunes Pereira, Mônica Pezenatto Dos Santos, Mônica Santiago Barbosa, Marília de Arruda Cardoso Smith, Spencer Luiz Marques Payão, Lucas Trevizani Rasmussen

Background: Helicobacter pylori (H. pylori) is a gram-negative bacterium associated with the etiology of several gastrointestinal tract pathologies, and cagA-positive (cagA+) strains are found in populations with gastric ulcers and precancerous lesions, inducing pro-inflammatory responses. The development of neoplasms is related to microRNA (miRNA) dysregulation, indicating highly expressed miRNA-629. The article aims to correlate the expression level of miRNA-629 with the presence of H. pylori and the pathogenicity marker cagA.

Methods: 203 gastric biopsy samples were evaluated from individuals with normal gastric tissue (n=60), gastritis (n=96), and gastric cancer (n=47) of both genders and over 18 years old. The samples were subdivided according to the presence or absence of H. pylori, detected by polymerase chain reaction (PCR). RNA was extracted using a commercial kit and quantified. Complementary DNA (cDNA) was synthesized using commercial kits, and the relative expression was calculated using the 2-ΔΔCt method.

Results: Individuals infected with H. pylori are nine times more likely to develop gastric cancer. Cancer patients appeared to have decreased expression of miRNA-629; however, the presence of the bacterium would not influence this reduction. Individuals in the cancer group showed lower miRNA-629 expression when cagA+; however, in the control group, the expression was higher when cagA+.

Conclusion: H. pylori is a factor involved in the etiology and progression of gastric diseases. Reduction in miRNA-629 expression in cancer patients occurs independent of the presence of the bacterium, but when the cagA pathogenicity marker is present, it induces changes in the gene expression of the respective miRNA.

背景:幽门螺杆菌(Helicobacter pylori,H. pylori)是一种革兰氏阴性菌,与多种胃肠道病变的病因有关,在胃溃疡和癌前病变人群中发现了 cagA 阳性(cagA+)菌株,可诱发促炎反应。肿瘤的发生与微RNA(miRNA)失调有关,这表明高表达的miRNA-629。本文旨在将 miRNA-629 的表达水平与幽门螺杆菌和致病标志物 cagA 的存在相关联。方法:对 203 份胃活检样本进行了评估,样本来自正常胃组织(n=60)、胃炎(n=96)和胃癌(n=47),男女均有,年龄均在 18 岁以上。通过聚合酶链反应(PCR)检测幽门螺杆菌的存在与否,对样本进行细分。使用商业试剂盒提取 RNA 并进行定量。使用商业试剂盒合成互补 DNA(cDNA),并使用 2-ΔΔCt 法计算相对表达量:结果:幽门螺杆菌感染者罹患胃癌的几率是正常人的九倍。癌症患者的 miRNA-629 表达量似乎有所下降;然而,幽门螺杆菌的存在并不会影响这种下降。癌症组中,当cagA+时,miRNA-629的表达量较低;但在对照组中,当cagA+时,miRNA-629的表达量较高:结论:幽门螺杆菌是胃病病因和进展的一个因素。癌症患者体内 miRNA-629 表达的减少与幽门螺杆菌的存在无关,但当存在 cagA 致病标记时,会诱导相应 miRNA 基因表达的变化。
{"title":"DECREASED EXPRESSION OF MICRORNA-629 IN GASTRIC CANCER SAMPLES POTENTIATED BY THE VIRULENCE MARKER OF H. PYLORI, CAGA GENE.","authors":"Caroline Dos Reis Rodrigues Soares, Lucas Matheus Vieira da Silva, Bianca Reis Almeida, Jéssica Nunes Pereira, Mônica Pezenatto Dos Santos, Mônica Santiago Barbosa, Marília de Arruda Cardoso Smith, Spencer Luiz Marques Payão, Lucas Trevizani Rasmussen","doi":"10.1590/S0004-2803.24612023-139","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612023-139","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori (H. pylori) is a gram-negative bacterium associated with the etiology of several gastrointestinal tract pathologies, and cagA-positive (cagA+) strains are found in populations with gastric ulcers and precancerous lesions, inducing pro-inflammatory responses. The development of neoplasms is related to microRNA (miRNA) dysregulation, indicating highly expressed miRNA-629. The article aims to correlate the expression level of miRNA-629 with the presence of H. pylori and the pathogenicity marker cagA.</p><p><strong>Methods: </strong>203 gastric biopsy samples were evaluated from individuals with normal gastric tissue (n=60), gastritis (n=96), and gastric cancer (n=47) of both genders and over 18 years old. The samples were subdivided according to the presence or absence of H. pylori, detected by polymerase chain reaction (PCR). RNA was extracted using a commercial kit and quantified. Complementary DNA (cDNA) was synthesized using commercial kits, and the relative expression was calculated using the 2-ΔΔCt method.</p><p><strong>Results: </strong>Individuals infected with H. pylori are nine times more likely to develop gastric cancer. Cancer patients appeared to have decreased expression of miRNA-629; however, the presence of the bacterium would not influence this reduction. Individuals in the cancer group showed lower miRNA-629 expression when cagA+; however, in the control group, the expression was higher when cagA+.</p><p><strong>Conclusion: </strong>H. pylori is a factor involved in the etiology and progression of gastric diseases. Reduction in miRNA-629 expression in cancer patients occurs independent of the presence of the bacterium, but when the cagA pathogenicity marker is present, it induces changes in the gene expression of the respective miRNA.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23139"},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH SEVERE COVID-19 AND CIRRHOSIS OR LIVER TRANSPLANT IN A BRAZILIAN QUATERNARY CENTER. 巴西一家四级中心的重度Covid-19和肝硬化或肝移植患者的临床特征和治疗效果。
Q2 Medicine Pub Date : 2024-05-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-145
Tulio L Correa, Mariana Sandoval Terra Campos Guelli, Ricardo Tavares de Carvalho

Background: Specific associations between liver cirrhosis and liver transplant with poorer outcomes in COVID-19 are still not completely clear.

Objective: We aimed to evaluate the clinical characteristics and outcomes of patients with severe COVID-19 and cirrhosis or liver transplant in Sao Paulo, Brazil.

Methods: A retrospective observational study was conducted in a quaternary hospital. Patients with COVID-19 and liver cirrhosis or liver transplant were selected. The clinical and demographic characteristics, as well as the outcomes, were assessed using electronic records.

Results: A total of 46 patients with COVID-19 and liver condition were included in the study. Patients with liver cirrhosis had significantly more endotracheal intubation and a higher relative risk of death than liver transplant recipients. Patients with higher MELD-Na scores had increased death rates and lower survival probability and survival time.

Conclusion: Patients with liver cirrhosis, especially those with higher MELD-Na scores, had poorer outcomes in COVID-19. Liver transplant recipients do not seem to be linked to poorer COVID-19 outcomes.

背景:在 COVID-19 中,肝硬化和肝移植与较差预后之间的具体关联仍不完全清楚:肝硬化和肝移植与 COVID-19 较差预后之间的具体关联仍不完全清楚:我们旨在评估巴西圣保罗严重 COVID-19 合并肝硬化或肝移植患者的临床特征和预后:在一家四级医院开展了一项回顾性观察研究。研究选择了 COVID-19 和肝硬化或肝移植患者。结果:共有46名COVID-19患者患有肝硬化或肝移植:研究共纳入了 46 名患有 COVID-19 和肝病的患者。与肝移植受者相比,肝硬化患者的气管插管次数明显增多,死亡的相对风险也更高。MELD-Na评分越高的患者死亡率越高,存活概率和存活时间越低:结论:肝硬化患者,尤其是 MELD-Na 评分较高的患者,在 COVID-19 中的预后较差。肝移植受者似乎与较差的 COVID-19 结果无关。
{"title":"CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH SEVERE COVID-19 AND CIRRHOSIS OR LIVER TRANSPLANT IN A BRAZILIAN QUATERNARY CENTER.","authors":"Tulio L Correa, Mariana Sandoval Terra Campos Guelli, Ricardo Tavares de Carvalho","doi":"10.1590/S0004-2803.24612023-145","DOIUrl":"10.1590/S0004-2803.24612023-145","url":null,"abstract":"<p><strong>Background: </strong>Specific associations between liver cirrhosis and liver transplant with poorer outcomes in COVID-19 are still not completely clear.</p><p><strong>Objective: </strong>We aimed to evaluate the clinical characteristics and outcomes of patients with severe COVID-19 and cirrhosis or liver transplant in Sao Paulo, Brazil.</p><p><strong>Methods: </strong>A retrospective observational study was conducted in a quaternary hospital. Patients with COVID-19 and liver cirrhosis or liver transplant were selected. The clinical and demographic characteristics, as well as the outcomes, were assessed using electronic records.</p><p><strong>Results: </strong>A total of 46 patients with COVID-19 and liver condition were included in the study. Patients with liver cirrhosis had significantly more endotracheal intubation and a higher relative risk of death than liver transplant recipients. Patients with higher MELD-Na scores had increased death rates and lower survival probability and survival time.</p><p><strong>Conclusion: </strong>Patients with liver cirrhosis, especially those with higher MELD-Na scores, had poorer outcomes in COVID-19. Liver transplant recipients do not seem to be linked to poorer COVID-19 outcomes.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23145"},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SPONTANEOUS REGRESSION OF HEPATOCELLULAR CARCINOMA: FOCUSING IN THE ASSOCIATED RISK FACTORS. 肝细胞癌的自发消退:关注相关风险因素
Q2 Medicine Pub Date : 2024-05-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-151
Cristiane Valle Tovo, Carolina Rossatto Ribas, Giovana Dal Pozzo Sartori, Gabriela Perdomo Coral, Eiji Suwa, Angelo Alves de Mattos

Background: Spontaneous regression (SR) is defined as the partial or complete disappearance of a tumor, in the absence of a specific treatment. Evidence of the SR in hepatocellular carcinoma (HCC) is rare.

Objective: The authors aimed to review all the cases of SR of HCC in two reference centers of Southern Brazil, highlighting the main characteristics.

Methods: Data of all patients with HCC were retrospectively reviewed looking for the occurrence of SR in patients from two tertiary centers in Southern Brazil, in the last five years. The diagnosis of cirrhosis was established according to clinical, laboratory and imaging data, as well as upper endoscopy or histopathological examination when necessary. The diagnosis of HCC was based on typical findings according to radiologic criteria (LIRADS) or histopathological examination. Spontaneous regression was defined as a partial or complete involution of a HCC in the absence of a specific therapy.

Results: From all cases of HCC in the last 5 years (n=433), there were five cases of SR. Three (60%) were men, the mean age was 62.6 (50.0-76.0) years, and the etiology was HCV in 3 (60%). Complete regression was observed in three patients (60%), one patient (20%) presented partial regression, and one (20%) relapesed and died. The time of follow-up varied between 12 and 21 months. In this presentation, it was highlighted one case of SR observed after COVID-19 infection in a patient with cirrhosis. The possible mechanisms involved in this situation were reviewed, emphasizing the most common like hypoxia and immunological. There were also one patient submitted to a surgical procedure as a possible fator involved and three patients without obvious risk factors.

Conclusion: This phenomenon will possibly contribute to a better understanding of the pathophysiological mechanisms of HCC.

背景:自发性消退(SR)是指在没有特定治疗的情况下,肿瘤部分或完全消失。肝细胞癌(HCC)中的自发消退证据非常罕见:作者旨在回顾巴西南部两家参考中心的所有 HCC SR 病例,并强调其主要特征:作者回顾性研究了所有 HCC 患者的数据,以了解巴西南部两家三级医疗中心在过去五年中发生 SR 的情况。肝硬化的诊断是根据临床、实验室和影像学数据以及必要时的上消化道内窥镜检查或组织病理学检查确定的。肝癌的诊断是根据放射学标准(LIRADS)或组织病理学检查的典型结果。自发性消退是指在没有特殊治疗的情况下,HCC部分或完全消退:在过去 5 年的所有 HCC 病例(n=433)中,有 5 例自发性消退。3例(60%)为男性,平均年龄为62.6(50.0-76.0)岁,3例(60%)的病因是HCV。3名患者(60%)的病情完全缓解,1名患者(20%)的病情部分缓解,1名患者(20%)的病情复发并死亡。随访时间从 12 个月到 21 个月不等。本报告重点介绍了一例肝硬化患者在感染 COVID-19 后出现 SR 的病例。报告回顾了这种情况可能涉及的机制,强调了最常见的机制,如缺氧和免疫机制。此外,还有一名接受过外科手术的患者可能与此有关,还有三名患者没有明显的危险因素:这一现象可能有助于更好地了解 HCC 的病理生理机制。
{"title":"SPONTANEOUS REGRESSION OF HEPATOCELLULAR CARCINOMA: FOCUSING IN THE ASSOCIATED RISK FACTORS.","authors":"Cristiane Valle Tovo, Carolina Rossatto Ribas, Giovana Dal Pozzo Sartori, Gabriela Perdomo Coral, Eiji Suwa, Angelo Alves de Mattos","doi":"10.1590/S0004-2803.24612023-151","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612023-151","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous regression (SR) is defined as the partial or complete disappearance of a tumor, in the absence of a specific treatment. Evidence of the SR in hepatocellular carcinoma (HCC) is rare.</p><p><strong>Objective: </strong>The authors aimed to review all the cases of SR of HCC in two reference centers of Southern Brazil, highlighting the main characteristics.</p><p><strong>Methods: </strong>Data of all patients with HCC were retrospectively reviewed looking for the occurrence of SR in patients from two tertiary centers in Southern Brazil, in the last five years. The diagnosis of cirrhosis was established according to clinical, laboratory and imaging data, as well as upper endoscopy or histopathological examination when necessary. The diagnosis of HCC was based on typical findings according to radiologic criteria (LIRADS) or histopathological examination. Spontaneous regression was defined as a partial or complete involution of a HCC in the absence of a specific therapy.</p><p><strong>Results: </strong>From all cases of HCC in the last 5 years (n=433), there were five cases of SR. Three (60%) were men, the mean age was 62.6 (50.0-76.0) years, and the etiology was HCV in 3 (60%). Complete regression was observed in three patients (60%), one patient (20%) presented partial regression, and one (20%) relapesed and died. The time of follow-up varied between 12 and 21 months. In this presentation, it was highlighted one case of SR observed after COVID-19 infection in a patient with cirrhosis. The possible mechanisms involved in this situation were reviewed, emphasizing the most common like hypoxia and immunological. There were also one patient submitted to a surgical procedure as a possible fator involved and three patients without obvious risk factors.</p><p><strong>Conclusion: </strong>This phenomenon will possibly contribute to a better understanding of the pathophysiological mechanisms of HCC.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23151"},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ADHERENCE AND PERSISTENCE TO TREATMENT WITH INFLIXIMAB: ANALYSIS OF A PATIENT SUPPORT PROGRAM COHORT IN BRAZIL. 英夫利西单抗治疗的依从性和持久性:对巴西患者支持计划队列的分析。
Q2 Medicine Pub Date : 2024-05-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612023-149
Aniela Bonorino Xexeo Castelo Branco, Wilton Argolo, Nathalia Santos, Gabriela Hernandez, Adriana Kakehasi, Carlos Walter Sobrado, Richard Melsheimer
<p><strong>Background: </strong>Monoclonal antibodies have proven efficacy in the management of several conditions and infliximab (IFX) is one of the most important drugs of the class. Some recent data have shown low rates of both persistence and adherence to several available biologics.</p><p><strong>Objective: </strong>The objective of this study was to describe adherence and persistence rate to IFX treatment and also persistence in the patient support program (PSP), among patients diagnosed with inflammatory bowel diseases (IBD) or rheumatic diseases (RD) enrolled in the program of a large pharmaceutical company in Brazil.</p><p><strong>Methods: </strong>Retrospective observational analysis using the PSP database. IBD or RD patients using IFX enrolled on the PSP database between September 2015 and August 2019 were retrospectively evaluated to identify the persistence rate and adherence and followed up until March 1, 2020. Patients were excluded if treatment start date was prior to program entry; first infusion prior to September 1st, 2015 or after August 31st, 2019; the patients did not started treatment; and patients with "OTHERS" in "Indication" field. Persistence was assessed considering both persistence in the program ("PSP persistence") and persistence on IFX in the PSP ("IFX persistence in the PSP"). PSP persistence was defined as the proportion of patients remaining in the program at 6, 12, 24, 36 and 48 months after initiating IFX. To determine IFX persistence in the PSP, censoring was defined at the time the patient left the program, died, or was lost to follow-up. Adherence to treatment was measured by medication possession ratio ((MPR) - All days supply / elapsed days from first prescription to last day of medication possession)). Descriptive statistics were initially used. Kaplan-Meier curve, the median time estimated by the survival function, Cox regression model, and restricted mean survival time (RMST) were used to evaluate the treatment persistence time at 24 months and the logistic regression model was performed aiming to identify variables associated with adherence (MPR ≥80%).</p><p><strong>Results: </strong>A total of 10,233 patients were analyzed, 5,826 (56.9%) with the diagnosis of RD and 4,407 (43.1%) of IBD. At the end of the follow-up (median 9.1 months from PSP entry to the last infusion), persistence in the PSP was 65.6%, 48.2%, 31.0%, 20.7% and 13.1% at 6, 12, 24, 36 and 48 months, respectively. Considering persistence on IFX in the PSP, estimates were 93.7%, 87.8%, 77.0%, 62.4% and 53.0% at 6, 12, 24, 36 and 48 months, respectively. Variables associated with the risk of non-persistence were gender, country region and diagnosis of rheumatoid arthritis and ankylosing spondylitis. Median MPR was 94.2%, while the percentage of patients with MPR ≥80% was 91.0%. Variables associated with MPR≥80% were country region and diagnosis of Crohn's disease.</p><p><strong>Conclusion: </strong>Many patients leave the program without
背景:单克隆抗体已被证明在多种疾病的治疗中具有疗效,英夫利昔单抗(IFX)是该类药物中最重要的药物之一。最近的一些数据显示,几种现有生物制剂的持续率和依从率都很低:本研究旨在对巴西一家大型制药公司的患者支持计划(PSP)中确诊为炎症性肠病(IBD)或风湿性疾病(RD)的患者对 IFX 治疗的依从性和坚持率以及对患者支持计划(PSP)的坚持率进行描述:方法:利用 PSP 数据库进行回顾性观察分析。对2015年9月至2019年8月期间在PSP数据库中登记使用IFX的IBD或RD患者进行回顾性评估,以确定持续率和依从性,并随访至2020年3月1日。如果治疗开始日期早于项目进入日期;首次输液日期早于 2015 年 9 月 1 日或晚于 2019 年 8 月 31 日;患者未开始治疗;以及 "适应症 "栏中填写 "其他 "的患者,则排除在外。评估持续性时,既要考虑在项目中的持续性("PSP 持续性"),也要考虑在 PSP 中 IFX 的持续性("IFX 在 PSP 中的持续性")。PSP 持续性是指患者在开始使用 IFX 后的 6、12、24、36 和 48 个月内仍留在项目中的比例。为确定 IFX 在 PSP 中的持续性,在患者离开项目、死亡或失去随访时进行剔除。治疗的依从性以药物持有率((MPR) - 所有供应天数/从首次处方到最后一天药物持有的天数)来衡量。)最初使用的是描述性统计。采用卡普兰-梅耶曲线、生存函数估算的中位时间、考克斯回归模型和限制性平均生存时间(RMST)来评估 24 个月的治疗持续时间,并建立逻辑回归模型,旨在确定与坚持治疗(MPR ≥80%)相关的变量:共分析了10233名患者,其中5826人(56.9%)被诊断为RD,4407人(43.1%)被诊断为IBD。在随访结束时(从进入PSP到最后一次输液的中位数为9.1个月),PSP的持续率在6、12、24、36和48个月时分别为65.6%、48.2%、31.0%、20.7%和13.1%。考虑到 PSP 中 IFX 的持续率,6、12、24、36 和 48 个月时的估计值分别为 93.7%、87.8%、77.0%、62.4% 和 53.0%。性别、国家地区以及类风湿关节炎和强直性脊柱炎的诊断与不持续风险相关。中位MPR为94.2%,而MPR≥80%的患者比例为91.0%。与MPR≥80%相关的变量有国家地区和克罗恩病诊断:结论:许多患者在未停用 IFX 的情况下离开了项目,因为项目和药物治疗估计值之间的 12 个月持续率差别很大,而在加入 PSP 的患者中观察到了较高的依从率。数据凸显了 PSP 的益处。
{"title":"ADHERENCE AND PERSISTENCE TO TREATMENT WITH INFLIXIMAB: ANALYSIS OF A PATIENT SUPPORT PROGRAM COHORT IN BRAZIL.","authors":"Aniela Bonorino Xexeo Castelo Branco, Wilton Argolo, Nathalia Santos, Gabriela Hernandez, Adriana Kakehasi, Carlos Walter Sobrado, Richard Melsheimer","doi":"10.1590/S0004-2803.24612023-149","DOIUrl":"10.1590/S0004-2803.24612023-149","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Monoclonal antibodies have proven efficacy in the management of several conditions and infliximab (IFX) is one of the most important drugs of the class. Some recent data have shown low rates of both persistence and adherence to several available biologics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The objective of this study was to describe adherence and persistence rate to IFX treatment and also persistence in the patient support program (PSP), among patients diagnosed with inflammatory bowel diseases (IBD) or rheumatic diseases (RD) enrolled in the program of a large pharmaceutical company in Brazil.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Retrospective observational analysis using the PSP database. IBD or RD patients using IFX enrolled on the PSP database between September 2015 and August 2019 were retrospectively evaluated to identify the persistence rate and adherence and followed up until March 1, 2020. Patients were excluded if treatment start date was prior to program entry; first infusion prior to September 1st, 2015 or after August 31st, 2019; the patients did not started treatment; and patients with \"OTHERS\" in \"Indication\" field. Persistence was assessed considering both persistence in the program (\"PSP persistence\") and persistence on IFX in the PSP (\"IFX persistence in the PSP\"). PSP persistence was defined as the proportion of patients remaining in the program at 6, 12, 24, 36 and 48 months after initiating IFX. To determine IFX persistence in the PSP, censoring was defined at the time the patient left the program, died, or was lost to follow-up. Adherence to treatment was measured by medication possession ratio ((MPR) - All days supply / elapsed days from first prescription to last day of medication possession)). Descriptive statistics were initially used. Kaplan-Meier curve, the median time estimated by the survival function, Cox regression model, and restricted mean survival time (RMST) were used to evaluate the treatment persistence time at 24 months and the logistic regression model was performed aiming to identify variables associated with adherence (MPR ≥80%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 10,233 patients were analyzed, 5,826 (56.9%) with the diagnosis of RD and 4,407 (43.1%) of IBD. At the end of the follow-up (median 9.1 months from PSP entry to the last infusion), persistence in the PSP was 65.6%, 48.2%, 31.0%, 20.7% and 13.1% at 6, 12, 24, 36 and 48 months, respectively. Considering persistence on IFX in the PSP, estimates were 93.7%, 87.8%, 77.0%, 62.4% and 53.0% at 6, 12, 24, 36 and 48 months, respectively. Variables associated with the risk of non-persistence were gender, country region and diagnosis of rheumatoid arthritis and ankylosing spondylitis. Median MPR was 94.2%, while the percentage of patients with MPR ≥80% was 91.0%. Variables associated with MPR≥80% were country region and diagnosis of Crohn's disease.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Many patients leave the program without","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23149"},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arquivos de Gastroenterologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1